4-acetamido-N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-2-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-3-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide

C156H171N37O8 — CID 158288240

IUPAC4-acetamido-N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-2-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-3-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide
SMILESCC(=O)Nc1ccc(C(=O)Nc2ccc(CCc3[nH]nc4ccnc(NC5CCCCC5)c34)cc2)cc1.Cn1cnc(C(=O)Nc2ccc(CCc3[nH]nc4ccnc(NC5CCCCC5)c34)cc2)c1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1ccccn1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1cccnc1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1ccncc1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1cocn1
InChIInChI=1S/C29H32N6O2.3C26H28N6O.C25H29N7O.C24H26N6O2/c1-19(36)31-23-14-10-21(11-15-23)29(37)33-24-12-7-20(8-13-24)9-16-25-27-26(35-34-25)17-18-30-28(27)32-22-5-3-2-4-6-22;33-26(19-5-4-15-27-17-19)30-21-11-8-18(9-12-21)10-13-22-24-23(32-31-22)14-16-28-25(24)29-20-6-2-1-3-7-20;33-26(23-8-4-5-16-27-23)30-20-12-9-18(10-13-20)11-14-21-24-22(32-31-21)15-17-28-25(24)29-19-6-2-1-3-7-19;33-26(19-12-15-27-16-13-19)30-21-9-6-18(7-10-21)8-11-22-24-23(32-31-22)14-17-28-25(24)29-20-4-2-1-3-5-20;1-32-15-22(27-16-32)25(33)29-19-10-7-17(8-11-19)9-12-20-23-21(31-30-20)13-14-26-24(23)28-18-5-3-2-4-6-18;31-24(21-14-32-15-26-21)28-18-9-6-16(7-10-18)8-11-19-22-20(30-29-19)12-13-25-23(22)27-17-4-2-1-3-5-17/h7-8,10-15,17-18,22H,2-6,9,16H2,1H3,(H,30,32)(H,31,36)(H,33,37)(H,34,35);4-5,8-9,11-12,14-17,20H,1-3,6-7,10,13H2,(H,28,29)(H,30,33)(H,31,32);4-5,8-10,12-13,15-17,19H,1-3,6-7,11,14H2,(H,28,29)(H,30,33)(H,31,32);6-7,9-10,12-17,20H,1-5,8,11H2,(H,28,29)(H,30,33)(H,31,32);7-8,10-11,13-16,18H,2-6,9,12H2,1H3,(H,26,28)(H,29,33)(H,30,31);6-7,9-10,12-15,17H,1-5,8,11H2,(H,25,27)(H,28,31)(H,29,30)
InChIKeyGLAVJMFNLILAFR-UHFFFAOYSA-N
MW2692.33 g/mol
LogP30.30
Rot. Bonds43

About 4-acetamido-N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-2-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-3-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide

4-acetamido-N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-2-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-3-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide (PubChem CID 158288240) has the molecular formula C156H171N37O8 and a molecular weight of 2692.33 g/mol. Its IUPAC name is 4-acetamido-N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-2-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-3-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide.

Molecular Properties

Compound Name4-acetamido-N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-2-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-3-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide
PubChem CID158288240
Molecular FormulaC156H171N37O8
Molecular Weight2692.33 g/mol
Exact Mass2690.41
IUPAC Name4-acetamido-N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-2-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-3-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide
SMILESCC(=O)Nc1ccc(C(=O)Nc2ccc(CCc3[nH]nc4ccnc(NC5CCCCC5)c34)cc2)cc1.Cn1cnc(C(=O)Nc2ccc(CCc3[nH]nc4ccnc(NC5CCCCC5)c34)cc2)c1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1ccccn1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1cccnc1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1ccncc1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1cocn1
InChIInChI=1S/C29H32N6O2.3C26H28N6O.C25H29N7O.C24H26N6O2/c1-19(36)31-23-14-10-21(11-15-23)29(37)33-24-12-7-20(8-13-24)9-16-25-27-26(35-34-25)17-18-30-28(27)32-22-5-3-2-4-6-22;33-26(19-5-4-15-27-17-19)30-21-11-8-18(9-12-21)10-13-22-24-23(32-31-22)14-16-28-25(24)29-20-6-2-1-3-7-20;33-26(23-8-4-5-16-27-23)30-20-12-9-18(10-13-20)11-14-21-24-22(32-31-21)15-17-28-25(24)29-19-6-2-1-3-7-19;33-26(19-12-15-27-16-13-19)30-21-9-6-18(7-10-21)8-11-22-24-23(32-31-22)14-17-28-25(24)29-20-4-2-1-3-5-20;1-32-15-22(27-16-32)25(33)29-19-10-7-17(8-11-19)9-12-20-23-21(31-30-20)13-14-26-24(23)28-18-5-3-2-4-6-18;31-24(21-14-32-15-26-21)28-18-9-6-16(7-10-18)8-11-19-22-20(30-29-19)12-13-25-23(22)27-17-4-2-1-3-5-17/h7-8,10-15,17-18,22H,2-6,9,16H2,1H3,(H,30,32)(H,31,36)(H,33,37)(H,34,35);4-5,8-9,11-12,14-17,20H,1-3,6-7,10,13H2,(H,28,29)(H,30,33)(H,31,32);4-5,8-10,12-13,15-17,19H,1-3,6-7,11,14H2,(H,28,29)(H,30,33)(H,31,32);6-7,9-10,12-17,20H,1-5,8,11H2,(H,28,29)(H,30,33)(H,31,32);7-8,10-11,13-16,18H,2-6,9,12H2,1H3,(H,26,28)(H,29,33)(H,30,31);6-7,9-10,12-15,17H,1-5,8,11H2,(H,25,27)(H,28,31)(H,29,30)
InChIKeyGLAVJMFNLILAFR-UHFFFAOYSA-N
XLogP30.30
TPSA607.82 Ų
H-Bond Donors19
H-Bond Acceptors32
Rotatable Bonds43
Heavy Atoms201
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002692.33
LogP ≤ 530.30
H-Bond Donors ≤ 519
H-Bond Acceptors ≤ 1032

Analyze 4-acetamido-N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-2-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-3-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-acetamido-N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-2-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-3-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide?
The IUPAC name of 4-acetamido-N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-2-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-3-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide (CID 158288240) is 4-acetamido-N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-2-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-3-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide.
What is the SMILES notation for 4-acetamido-N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-2-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-3-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide?
The canonical SMILES for 4-acetamido-N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-2-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-3-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide is CC(=O)Nc1ccc(C(=O)Nc2ccc(CCc3[nH]nc4ccnc(NC5CCCCC5)c34)cc2)cc1.Cn1cnc(C(=O)Nc2ccc(CCc3[nH]nc4ccnc(NC5CCCCC5)c34)cc2)c1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1ccccn1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1cccnc1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1ccncc1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1cocn1.
What is the InChIKey of 4-acetamido-N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-2-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-3-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide?
The InChIKey is GLAVJMFNLILAFR-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H32N6O2.3C26H28N6O.C25H29N7O.C24H26N6O2/c1-19(36)31-23-14-10-21(11-15-23)29(37)33-24-12-7-20(8-13-24)9-16-25-27-26(35-34-25)17-18-30-28(27)32-22-5-3-2-4-6-22;33-26(19-5-4-15-27-17-19)30-21-11-8-18(9-12-21)10-13-22-24-23(32-31-22)14-16-28-25(24)29-20-6-2-1-3-7-20;33-26(23-8-4-5-16-27-23)30-20-12-9-18(10-13-20)11-14-21-24-22(32-31-21)15-17-28-25(24)29-19-6-2-1-3-7-19;33-26(19-12-15-27-16-13-19)30-21-9-6-18(7-10-21)8-11-22-24-23(32-31-22)14-17-28-25(24)29-20-4-2-1-3-5-20;1-32-15-22(27-16-32)25(33)29-19-10-7-17(8-11-19)9-12-20-23-21(31-30-20)13-14-26-24(23)28-18-5-3-2-4-6-18;31-24(21-14-32-15-26-21)28-18-9-6-16(7-10-18)8-11-19-22-20(30-29-19)12-13-25-23(22)27-17-4-2-1-3-5-17/h7-8,10-15,17-18,22H,2-6,9,16H2,1H3,(H,30,32)(H,31,36)(H,33,37)(H,34,35);4-5,8-9,11-12,14-17,20H,1-3,6-7,10,13H2,(H,28,29)(H,30,33)(H,31,32);4-5,8-10,12-13,15-17,19H,1-3,6-7,11,14H2,(H,28,29)(H,30,33)(H,31,32);6-7,9-10,12-17,20H,1-5,8,11H2,(H,28,29)(H,30,33)(H,31,32);7-8,10-11,13-16,18H,2-6,9,12H2,1H3,(H,26,28)(H,29,33)(H,30,31);6-7,9-10,12-15,17H,1-5,8,11H2,(H,25,27)(H,28,31)(H,29,30).
What are the key properties of 4-acetamido-N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-2-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-3-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide?
4-acetamido-N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-2-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-3-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide has a molecular weight of 2692.33 g/mol, XLogP of 30.30, 43 rotatable bonds, 19 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 4-acetamido-N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-2-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-3-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide is sourced from PubChem (CID 158288240), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).